Skip to Main Content

Paper Details

Preclinical Development of Brain Permeable ERβ Agonist for the Treatment of Glioblastoma.
Mol Cancer Ther
1
2023
Author NameAffiliation
Yidong ChenGreehey Children's Cancer Research Institute, University of Texas Health San Antonio
Yidong ChenUniversity of Texas Health San Antonio
  • 1 - 2

Datasets

Release 1.2